-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Biote, Lowers Price Target to $4

Benzinga·04/16/2026 14:32:58
Listen to the news
Truist Securities analyst Gregory Fraser maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $5 to $4.